Table 6.
Growth inhibition studies were performed as described for Table 3. Cells were incubated in serial dilutions of 4da for 3 days before determining viable cell numbers relative to untreated cells.
Cell Line or Strain |
Cell Type | Inhibition (IC50, µM) |
---|---|---|
H460 | lung cancer | 15.9 ± 1.1 |
HeLa | uterine cervical cancer | 10.8 ± 0.8 |
HEK-293 | embryonic kidney | 10.4 ± 1.3 |
JJN3 | myeloma | 15.7 ± 0.9 |
INA-6 | myeloma | 18.1 ± 0.8 |
IH-1 | myeloma | 20.6 ± 1.1 |
ANBL-6 | myeloma | 35.6 ± 2.6 |
KJON | myeloma | 23.0 ± 2.6 |
U266 | myeloma | 46.0 ± 3.2 |
HO15.19 (myc−/−) | rat fibroblasts | 20.6 ± 1.0 |
HO15.19-wt-Myc | rat fibroblasts | 14.1 ± 1.2 |